Delivery Order SPE2DB24D2101-SPE2DB25FKNGH
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,597.56 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, non-set-aside contract will be completed by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical...
- The Defense Logistics Agency awarded a $3,729.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Actemra 200 mg/10 mL vials. The contract, which is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a $8,243.54 delivery order to AmerisourceBergen Drug Corp for 4,569,930,973 units of Actemra 400 mg/20 ml vials. This is a non-set-aside, competitively awarded firm fixed-price delivery order with a completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Actemra 400 mg/20 ml vials with a ceiling value of $3,543.28 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made on a competitive basis...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Actemra 400 mg/20 ml vials, with a contract ceiling value of $3,788.05 and an ultimate completion date of November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials with a ceiling value of $6,630.33. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of June 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $20,481.14 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of May 9, 2025, and performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9,893.76 for the supply of Actemra 400 mg/20 ml vials on August 26, 2025, with completion targeted for August 27, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under the vendor's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,893.76 to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials. The contract is a firm fixed-price delivery order with a completion date of September 5, 2025, and was awarded on September 4, 2025, with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,471.52 to AmerisourceBergen Drug Corp for the supply of Actemra 200 mg/10 mL vials on July 3, 2025, with a completion date of July 7, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $1 billion through December 2026. The place of performance...